Who owns ASSEMBLY BIOSCIENCES INC?
- Ticker: ASMB
- CUSIP Number: 045396207
Tip: Access positions for across all investors
Analyze quarterly positions in Assembly Biosciences with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Assembly Biosciences stock
Who bought or sold ASSEMBLY BIOSCIENCES INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Gilead Sciences | 4.5M | $153M | 0% | Dec 2025 |
|
| Farallon Capital Management | 1.2M | $42M | 0% | Dec 2025 |
|
| RA Capital Management | 1.0M | $26M | 100% | Sep 2025 |
|
| Commodore Capital | 1.0M | $34M | 0% | Dec 2025 |
|
| Henderson Group | 753k | $19M | 100% | Sep 2025 |
|
| Paradigm Biocapital Advisors | 665k | $23M | 100% | Dec 2025 |
|
| Point72 Asset Management | 601k | $20M | 103% | Dec 2025 |
|
| Vanguard Group | 573k | $20M | 14% | Dec 2025 |
|
| Blackstone Group | 448k | $12M | 100% | Sep 2025 |
|
| Parkman Healthcare Partners | 249k | $8.5M | -1% | Dec 2025 |
|
| Franklin Resources | 211k | $7.2M | -12% | Dec 2025 |
|
| BlackRock | 192k | $6.5M | 13% | Dec 2025 |
|
| Eversept Partners | 160k | $5.4M | 100% | Dec 2025 |
|
| Stempoint Capital | 157k | $5.3M | 137% | Dec 2025 |
|
| Geode Capital Management | 131k | $4.5M | 1% | Dec 2025 |
|
| Marshall Wace | 129k | $4.4M | 51% | Dec 2025 |
|
| Patient Square Capital | 127k | $4.3M | -6% | Dec 2025 |
|
| Caption Management | 107k | $3.6M | -70% | Dec 2025 |
|
| Susquehanna International | 80k | $2.7M | -64% | Dec 2025 |
|
| Superstring Capital Management | 65k | $2.2M | 100% | Dec 2025 |
|
| Schonfeld Strategic Advisors | 54k | $1.8M | -56% | Dec 2025 |
|
| Citadel Advisors | 54k | $1.4M | 51% | Sep 2025 |
|
| Jane Street | 54k | $1.8M | 59% | Dec 2025 |
|
| State Street Corporation | 53k | $1.8M | 18% | Dec 2025 |
|
| Qube Research & Technologies | 42k | $1.4M | 282% | Dec 2025 |
|
| Northern Trust | 41k | $1.4M | 3% | Dec 2025 |
|
| Monimus Capital Management | 38k | $1.3M | -9% | Dec 2025 |
|
| Arrowstreet Capital, Limited Partnership | 38k | $1.3M | 100% | Dec 2025 |
|
| Palumbo Wealth Management | 37k | $1.3M | 7% | Dec 2025 |
|
| Goldman Sachs Group | 35k | $1.2M | 97% | Dec 2025 |
|
| Ellsworth Advisors | 30k | $889k | -1% | Dec 2025 |
|
| Eudaimonia Asset Management | 30k | $1.0M | 2% | Dec 2025 |
|
| Trexquant Investment | 28k | $962k | 126% | Dec 2025 |
|
| 683 Capital Management | 28k | $948k | 100% | Dec 2025 |
|
| Federated Investors | 25k | $864k | 0% | Dec 2025 |
|
| Barclays | 25k | $841k | 525% | Dec 2025 |
|
| Millennium Management | 22k | $553k | 100% | Sep 2025 |
|
| Connor, Clark & Lunn Investment Management | 21k | $708k | 86% | Dec 2025 |
|
| ADAR1 Capital Management | 20k | $672k | 4% | Dec 2025 |
|
| Sei Investments | 18k | $604k | 100% | Dec 2025 |
|
| Cubist Systematic Strategies | 16k | $414k | 100% | Sep 2025 |
|
| OMERS Administration Corporation | 16k | $531k | 100% | Dec 2025 |
|
| Bridgeway Capital Management | 15k | $390k | 0% | Sep 2025 |
|
| Hudson Bay Capital Management | 15k | $512k | 100% | Dec 2025 |
|
| Susquehanna Portfolio Strategies | 14k | $473k | 100% | Dec 2025 |
|
| Raymond James Financial | 13k | $445k | 100% | Dec 2025 |
|
| GSA Capital Partners | 13k | $432k | 2% | Dec 2025 |
|
| Acadian Asset Management | 12k | $422k | -47% | Dec 2025 |
|
| Engineers Gate Manager | 10k | $353k | 100% | Dec 2025 |
|
| UBS Group | 9.8k | $333k | -38% | Dec 2025 |
|
| Renaissance Technologies | 9.2k | $314k | -94% | Dec 2025 |
|
| Charles Schwab Investment Management | 6.7k | $228k | 100% | Dec 2025 |
|
| Seven Fleet Capital Management | 4.3k | $147k | 100% | Dec 2025 |
|
| Tower Research Capital | 607.00 | $21k | 100% | Dec 2025 |
|
| Northwestern Mutual Wealth Management Company | 260.00 | $8.8k | 0% | Dec 2025 |
|
| Rhumbline Advisers | 190.00 | $6.5k | 0% | Dec 2025 |
|
| Farther Finance Advisors | 154.00 | $5.2k | 100% | Dec 2025 |
|
| Advisor Group Holdings | 100.00 | $3.4k | 0% | Dec 2025 |
|
| Us Bancorp | 59.00 | $2.0k | 100% | Dec 2025 |
|
| EverSource Wealth Advisors | 55.00 | $1.9k | 0% | Dec 2025 |
|
| Hanson McClain Advisors | 32.00 | $1.1k | 100% | Dec 2025 |
|
| Quadrant Capital | 22.00 | $749.001000 | 0% | Dec 2025 |
|
| Point72 Europe | 13.00 | $332.000500 | 100% | Sep 2025 |
|
| Jpmorgan Chase & Co | 7.00 | $178.999800 | 100% | Sep 2025 |
|
| Bnp Paribas Arbitrage, Snc | 2.00 | $68.000000 | -97% | Dec 2025 |
|
Who sold out of Assembly Biosciences?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Frazier Life Sciences Management | Sep 2025 | 456k | $12M |
| MPM Oncology Impact Management | Sep 2025 | 40k | $1.0M |
| Walleye Trading Advisors | Sep 2025 | 25k | $627k |
| XTX Topco | Sep 2025 | 13k | $328k |
| Wells Fargo & Company | Sep 2025 | 145.00 | $3.7k |
| SBI Securities | Sep 2025 | 68.00 | $1.7k |
| Royal Bank of Canada | Jun 2025 | 53.00 | $999.998700 |